RxDoctor Payments Data

Jorge Monroy Avella

General Practice · Ocoee, FLNPI 1265860225

Payments from drug & device makers

What this record shows

Modernatx, Inc. accounts for 87.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $1,390 and has fallen 98.8% since, to $16 in 2025.

$1,595in general payments, 2019–2025

Across 9 payments — averaging $177.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$1K
  • Merck$135
  • Sanofi US Services Inc.$54
  • Shield Therapeutics Inc$16
$10,566,301in research payments, 2019–2025

Across 938 payments — averaging $11,265 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$9.2M
  • Bavarian Nordic A/s$892K
  • Sanofi Pasteur Inc.$155K
  • E.r. Squibb & Sons, L.L.C.$114K
  • Pfizer$55K
  • Mylan Specialty L.p.$51K
  • plus $83K from 2 others

What the payments were for

  • Travel & lodging$88355%
  • Food & beverage$71245%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,595 in reported general payments places this provider in the 85th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium16$150
Atorvastatin Calcium14$102
Metformin Hcl18$32

Paid to pharmacies, not to this prescriber.

Other general practice in Ocoee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →